Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway

Kurt Lucas; Michael Maes

doi:10.1007/s12035-013-8425-7

Related publications

Article2015

The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue

Kurt Lucas, Gerwyn Morris, George Anderson, Michael Maes

Article2002

Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers

Trude H. Flo, Liv Ryan, Eicke Latz, Osamu Takeuchi, Brian G. Monks, Egil Lien, Øyvind Halaas, Akira Shizuo, Gudmund Skjåk‐Bræk, Douglas T. Golenbock, Terje Espevik

Journal of Biological Chemistry

Article2000

Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways

Shintaro Sato, Fumiko Nomura, Taro Kawai, Osamu Takeuchi, Peter F. Mühlradt, Kiyoshi Takeda, Akira Shizuo

The Journal of Immunology

Article2003

Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

Masahiro Yamamoto, Shintaro Sato, Hiroaki Hemmi, Katsuaki Hoshino, Tsuneyasu Kaisho, Hideki Sanjo, Osamu Takeuchi, Masanaka Sugiyama, Masaru Okabe, Kiyoshi Takeda, Akira Shizuo

Science

Article2016

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis

Rh.Ll. Smith, Harry L. Hébert, Jonathan Massey, John Bowes, Helena Marzo‐Ortega, Pauline Ho, Neil McHugh, Jane Worthington, Anne Barton, Christopher Em Griffiths, Richard B. Warren